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Abstract 
Patients in modern healthcare demand superior healthcare quality. Clinical pathways are introduced 
as the main tools to manage this quality. A clinical pathway is a task-oriented care plan that specifies 
steps to be taken for patient care. It follows the clinical course according to the specific clinical problem. 
During clinical pathway execution, variance or deviation from the specified care plan could occur, and 
may endanger the patient’s life. In this paper, a proposed framework for artificial neural networks 
(ANNs) in clinical pathway variance predictions is presented. This proposed research method predicts 
the variance that may occur during Acute Decompensated Heart Failure Clinical Pathway. By using 
the Artificial Neural Network, 3 variances (Dialysis, PCI, and Cardiac Catherization) are predicted from 
55 input. The results show that artificial neural networks with the Levenberg-Marquadt training 
algorithm with a 55-27-27-1 architecture achieve the best prediction rate, with an average prediction 
accuracy of 87.4425% for the training dataset and 85.255% for the test dataset. 
Keywords: Artificial neural network, acute decompensated heart failure, variance prediction, clinical 
pathway 
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INTRODUCTION 
A clinical pathway (CP) is set of tools which plays an important 
role in improving the quality of patient care and increasing healthcare 
organizations’ efficiency by supporting the standardized treatment 
process. Clinical pathways were introduced in the mid-1980s by Zander 
and Bower, and can be described as the guidelines for clinical practice 
for specific groups of patients, based on a particular diagnosis. Clinical 
pathways specify the categories of care, activities, and procedures that 
need to be conducted for the patient until they are discharged from the 
hospital, displayed in a timeline. Deviation of actual care from the 
standardized care activity may happen anytime during an episode of 
care, which is called variance, and is also managed and handled by the 
clinical pathway. 
Clinical pathways can bring benefits to the healthcare provider. 
Among their benefits are: 1) improve patient clinical outcomes; 2) help 
to reduce hospital costs and help hospital management to optimize 
resources in terms of equipment or personnel. Common practice of 
clinical pathways requires medical professionals to manually fill in 
predefined paper documents. This practice, known as a paper-based 
clinical pathway, is limited and not dynamic, which brings several 
problems. These problems include: 
1) Limited to just the capacity of data collection and recording. 
2) Separated from the hospital information system. 
3) Lack of support for real time patient monitoring.
4) The complex logical and timed relationship of different
activities cannot be described with the simple description in
term of forms.
5) Unable to detect and handle variance dynamically.
 To overcome some of these problems, an electronic clinical 
pathway is introduced. Efforts to develop computerized or electronic 
clinical pathways have already been going since the 1990s, when the 
linear sequential model of the electronic clinical pathway was 
developed in early 1990s. Since then, electronic clinical pathways 
evolved to state transition models of electronic clinical pathways in the 
late 1990s, the structural design was adapted in the 2000s, and was 
further developed to utilize an ontological design in 2007. Furthermore, 
the capability of electronic clinical pathways was further enhanced by 
embedding the electronic clinical pathway with electronic medical 
records and integrating the electronic clinical pathway with the nursing 
process.  
Most of the current practice around electronic clinical pathways is 
not dynamic or adaptive. During the event of variance, most of the 
current electronic clinical pathways only provide the means to detect, 
record, or handle the variance occurrence. Most of the methods 
proposed for variance management in clinical pathways usually deal 
with one type of variance and rely on the fuzzy rules provided by the 
domain expert, which are difficult to obtain. 
This research proposes a method to predict variance during clinical 
pathways in order to give better preparation for the treatment. Artificial 
Neural Networks (ANN) prove to be powerful tools for mapping 
nonlinear data, and are known to be useful in solving nonlinear 
problems where the rules to solve the problem are difficult to obtain or
are unknown. This paper proposes the use of artificial neural networks
to predict variance for acute decompensated heart failure (ADHF)
clinical pathways. The objective of this paper is to show the framework
of artificial neural networks for variance prediction in ADHF clinical
pathways. 
RESEARCH ARTICLE 
RELATED WORKS 
reasoning  engine.   This   system  can  be  implemented to any clinical 
pathway. 
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Table 1 Review on selected clinical pathway variance studies.
 
Author, 
Year 
Field Clinical 
Pathway 
Proposed 
Method 
S. 
Wakamiya 
and K. 
Yamauchi 
(2006)  
Variance 
documentation, 
classification, 
and analysis 
Various Electronic 
system for 
paper based 
clinical pathway 
management 
that is capable 
of 
documenting, 
classifying, and 
analyzing 
variances 
Kate L. 
Hyet et al 
(2007)  
Variance 
documentation, 
classification, 
and analysis 
Various Clinical 
variance 
management 
and analysis 
application are 
proposed 
Xiang Li 
et al 
(2014)  
Variance 
analysis 
Congestive 
heart failure 
Automated 
clinical pathway 
variance 
analysis for 
multistage 
clinical 
pathways is 
proposed   
Yan Ye et 
al (2006)  
Variance 
handling 
General Proposed 
generalized 
fuzzy ECA 
(GFECA) rules 
and typed fuzzy 
petri net 
extended by 
process 
knowledge 
(TFPN-PK) 
models for 
analysis and 
handling of 
clinical pathway 
variances 
Gang Du 
et al 
(2012)  
Variance 
Handling 
Osteosarcoma 
preoperative 
chemotherapy  
Takagi-Sugeno 
(T-S) fuzzy 
neural network 
with random 
cooperative 
decomposing 
particle swarm 
optimization 
algorithm 
(RCDPSO) and 
discrete binary 
version of PSO 
algorithm 
learning 
algorithm 
Gang Du 
et al 
(2013)  
Variance 
Handling 
Osteosarcoma 
preoperative 
chemotherapy 
Takagi-Sugeno 
(T-S) fuzzy 
neural network 
with random 
cooperative 
decomposing 
particle swarm 
optimization 
double mutation 
mechanism 
enhancement 
learning 
algorithm 
(RCDPSO_DM) 
	
Most of the research on clinical pathways mainly focuses on 
documenting, classifying, analyzing, and handling variances. 
Documenting variance deals with the aspect of recording its 
occurrences, while classifying variances will help the clinical pathway 
to identify what type of variance (system variance, staff variance, or 
patient variance) occurs and whether the variance is good (e.g. 
decreasing of patient’s length of stay), or bad (e.g. patient 
complications during treatment). Table 1 shows a review on the 
research of clinical pathway variances. 
S. Wakamiya and K. Yamauchi have proposed a system that is 
capable of managing clinical pathway variances. Low-cost 
implementation and portability are the main features of the proposed 
systems. Systems prior to the systems proposed by Wakamiya and 
Yamauchi needed specialized hardware and software, which are not 
easy to adapt for the use of other institutions. The proposed system 
could be implemented to various clinical pathways. Clinical pathways 
that have been implemented using the proposed systems are 
Gastroenteritis, Cardiac Catheterization, Bronchitis, Pneumonia, 
Cataracts, Acute Myocardial Infraction, Transurethral 
Ureterolithorispy and Infant Bruising. 
Clinical variance management and analysis (CVMA) applications 
were proposed by Kate L. Hyet et al. in 2007. This application is 
designed to collect variance data for documentation, classification, 
and analysis of variance. The variance analysis application enabled 
the collection of variance data from clinical pathways and can readily 
be changed to accommodate new clinical pathways or additional 
variances. Unfortunately, this application is not integrated with 
electronic medical records or any electronic clinical pathway systems. 
The capabilities of this system are limited to managing reported 
variance data, and are unable to automatically redesign clinical 
pathways based on the reported variances. 15 clinical pathways are 
used in this study, which covers small rural hospitals and large 
regional hospitals. 
A method for automated variance identification and analysis was 
proposed by Xiang Li et al. in 2014. The proposed method is able to 
automatically identify the deviation between actual patient traces in 
electronic medical records and a multistage clinical pathway. The 
clinical pathway variance analysis method proposed by Xian Li et al 
uses a clinical pathway and patient traces of cohort in Electronic 
Medical Records as inputs, and the variance analysis report as an 
output. The clinical pathway use in this study is the congestive heart 
failure clinical pathway. Even though the proposed method is able to 
identify deviation in the clinical pathway, it is still unable to define 
whether the deviation is positive (e.g. reduce length of stay) or 
negative outcomes (e.g. prolonged length of stay). 
Several researchers have proposed methods for variance handling. 
Yan Ye et al. (2009) presented a knowledge-based variance 
management system which has been developed based on unified 
modeling language (UML) with the use of generalized fuzzy ECA 
(GFECA) rules and typed fuzzy petri net extended by process 
knowledge (TFPN-PK) models for analysis and handling of clinical 
pathway variances. The architecture of the proposed system consists 
of three levels, which are the client level, application level, and 
knowledge base levels. The client level consists of a user interface for 
different types of users and the clinical pathway workflow system. 
The application level consists of four modules, including a fuzzy 
reasoning and variance handling engine. The knowledge based level 
consists of medical knowledge which is represented using ontology. 
The variance handling engine is activated by the clinical pathway
workflow system when the variance information and handling request 
is sent. The engine searches for the appropriate rules matching the 
variances in the GFECA rule base. If the rules are found, it performs 
rule reasoning; otherwise it activates the TFPN-PK based fuzzy 
2) Able to recognize complex   non-linear relationships between 
Procedure  and  treatment  for  heart failure patient taken from 
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Gang Du et al proposed the use of the Takagi-Sugeno (T-S) fuzzy 
neural network with a novel hybrid learning algorithm for handling 
variances in liver poisoning of the osteosarcoma preoperative 
chemotherapy clinical pathway. The proposed method integrates the 
random cooperative decomposing particle swarm optimization 
algorithm (RCDPSO) and the discrete binary version of the PSO 
algorithm to optimize the structures and parameters of the T-S fuzzy 
neural network. The fuzzy neural network based variance handling 
method recommends the dosage of liver protection drugs based on two 
lab tests (Alanine Aminotransferase and Aspartate AminoTransferase) 
and the patient experience index. Even though the proposed method 
successfully improves the optimization performance, it still has a 
premature convergence and low precision that has not been solved 
completely. With the implementation of a double mutation in 
RCDPSO, the aforementioned problems are resolved. 
Even though recent research has proposed the management of 
variance of clinical pathways, there is still a lack of a variance handling 
method that can detect and handle variances at the same time.  It is 
important for clinical pathways to be able to detect and handle variances 
effectively to provide high quality care to the patient. 
METHODS 
This research proposed the application of a neural network to 
predict variance, deviation, or additional procedures for a heart failure 
clinical pathway. The case study used in this study is based on an Acute 
Decompensated Heart Failure (ADHF) clinical pathway. Data is taken 
from National Heart Institute (IJN) in Kuala Lumpur, Malaysia.  
Based on the data collected, we have established the main treatment 
and variance that occurred during acute decompensated heart failure 
clinical pathway. Table 2 shows the overall number of procedures and 
treatments that were completed and recorded in the IJN Cardiology 
ADHF database. 
Table 2 
IJN databases. 
Treatment/Procedure 
Number of 
Treatments 
Recorded 
Percentage 
Diuretic Prescription 4138 92.00% 
Aspirin Prescription 2671 59.42% 
Digoxin 1925 42.82% 
Clopidogrel Prescription 1780 39.59% 
Dialysis  173 3.80% 
PCI  64 1.42% 
Angiography 278 6.18% 
Cardiac Catheterization  44 0.90% 
Based on Table 2, most of the patients have been treated using 
noninvasive treatment, where the most common treatment was using 
diuretic drugs. However, some of the patients required alternative or 
additional treatments and procedures for their condition. These 
additional procedures included Angiography and Cardiac 
Catheterization, and additional treatments included PCI and Dialysis 
treatment. 
Dialysis is a process involving removing waste and excess water 
from the blood, and is used for those who have lost kidney function or 
for those with acute disturbance in kidney function. Percutaneous 
Coronary Intervention (PCI) is non-surgical revascularization 
technique used for treating obstructive coronary artery diseases, 
including unstable angina, multi vessel coronary disease (CAD), and 
acute myocardial infarction (MI). Angiography is a medical imaging 
technique used to visualize blood vessels, which is mainly used to 
visualize arteries, veins, or heart chambers. Cardiac catheterization 
(Card Cath) is a heart examination procedure to find out how well your 
heart is working. This research aims to predict these three additional 
treatments and procedures using an artificial neural network. 
ANN framework for ADHF variance prediction 
In this section, we briefly introduce the basic neural network 
concept for clinical pathway variance prediction. A neural network 
consists of an interconnected group of artificial neurons, and it 
processes information using a connectionist approach to computation. 
ANN has been implemented in various fields. In healthcare, ANN is 
implemented for clinical diagnosis, drug development, image analysis, 
and signal analysis. ANN has proven to be useful for modeling complex 
relationships between inputs and outputs, or to find patterns in data. 
Others advantages of ANN are: 
1) Requires less formal statistical training to develop 
independent and dependent variables 
3) Capable of discovering all possible interactions between predictor 
values 
4) Can be developed using different training algorithms. 
Even though ANN is a powerful tool for prediction and has been 
widely used, it still depends on a trial and error process in order to 
obtain the successful model. Until now, there were no clear rules on 
how to obtain the best and most successful model of ANN. Since ANN 
is fully dependent on a trial and error process, there were 5 influencing 
factors that contributed to the best ANN model. These influencing 
factors are network structure, network algorithm, transfer function, 
training function, and performance function. These factors can be 
summarized as a neural network configuration. 
Furthermore, data setup can also influence the effectiveness of the 
ANN model. In data setup, the collected raw data will be processed 
before being used for the ANN model. This process is also known as 
data preprocessing. After data processing is completed, the dataset will 
be divided into training and test datasets. 
Data Setup 
Data used for this research was collected from the Cardiology 
Medical Record (Acute Decompensated Heart Failure) Database in the 
National Heart Institute (IJN) of Malaysia. The data collected consists 
of 4495 patients between the period of 1st January 2009 – 22nd 
December 2015. Data is taken from the IJN Cardiology Medical Record 
Acute Decompensated Heart Failure (ADHF) Database. Based on the 
data analysis, we have determined 55 inputs and 3 outputs for the ANN 
model. Table 3 shows the inputs and outputs of the proposed neural 
network for ADHF variance prediction.  
After the data is obtained, data preprocessing is conducted. Data 
cleaning and transformation are primarily used for data preprocessing 
in our dataset. Data cleaning involves filling in missing values in the 
dataset, smoothing the noisy data, and resolving inconsistencies in 
dataset. Missing values are the main issue in our dataset, where the 
dataset contains a lot of missing data resulting in misplaced data and 
human error. These missing values is filled using equation (1). 
𝐗 =  
𝟏
𝒏
∑ 𝒃𝒊 =  
𝟏
𝒏
 (𝒃𝟏 +  𝒃𝟐 + ⋯ + 𝒃𝒏
𝒏
𝒊=𝟏
)  (1) 
Where X is the value of missing data, n is the number of attributes in 
missing data classes, and b is the value of individual attributes in the 
missing data classes.  
Data transformation techniques are applied after the data cleaning 
process is completed. Data transformation consolidated data into forms 
that are appropriate for the use of the neural network model. The raw 
data consisted of string and date/time data that the neural network 
cannot process. So these data need to be transformed to numerical or 
Boolean data types. Table 4 shows the examples of data transformation 
for the ANN dataset. 
Inputs and outputs of proposed variance prediction using ANN. 
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Table 3 
INPUT OUTPUT 
1. Gender 
2. Age 
3. Weight 
4. Height 
5. Smoking Habits 
6. Previous Heart Failure 
Hospitalization 
7. Pre Hospital LVEF 
8. Coronary Artery Disease 
9. Previous PCI Procedure 
10. Previous CABG Procedure 
11. Previous MI 
12. Renal Insufficiency 
13. Creatinine more than 37 
14. Regular Dialysis 
15. Atrial Fibrillation 
16. Diabetes 
17. Hypertension 
18. Hyperlipidemia/Dyslipidemia 
19. Stroke 
20. COPD/Asthma 
21. Dyspnea 
22. Peripheral Edema 
23. Ascites 
24. Lung Crepitation 
25. Elevated JVP 
26. Hepatomegaly 
27. Admission Systolic BP 
28. Admission Diastolic BP 
29. Admission Heart Rate 
30. Admission Respiratory Rate 
31. ECG Procedure Done 
32. Rhythm ID 
33. Q Wave 
34. ST Segment Depression 
35. ST Segment Elevation 
36. No Infarction Evidence 
37. QRS Duration 
38. X-ray Procedure 
39. Cardiomegaly 
40. Pleural Effusion 
41. Congestion 
42. Ill-defined Opacity 
43. Acute Pulmonary Edema 
44. Urea Level 
45. Sodium Level 
46. Potassium Level 
47. Creatinine Level 
48. Uric Acid Level 
49. Random Blood Sugar Test 
50. Bilirubin Level 
51. Albumin Level 
52. CK Level 
53. Hemoglobin Test 
54. Admission LVEF 
55. LVEF not done 
1. Dialysis Procedure 
2. PCI Procedure 
3. Angiography 
Procedure 
4. Cardiac Catheter 
Procedure 
Table 4  Data transformation examples. 
Input Classes Transformed Data 
Gender Male → 0, Female → 1
Previous MI (Myocardial 
Infarction) 
Does not have → 0, Have → 1
 
Date of birth  → Age
 
04-12-88  → 28
 
After data processing is completed, the dataset needs to be divided 
into training and test datasets. The data division process is an important 
part of evaluating neural network models. The training dataset is used 
by neural network models to discover potentially predictive 
relationships. The test dataset is used to evaluate the performance of the 
neural network model. This research used the k-fold cross validation 
technique. K-fold cross validation randomly partitioned into k equal 
size of subsamples. For this research, we use k value that used is 10 
which means the dataset is partition into 10 samples. Of 10 partitions, 
a single partition of samples is used as test data to validate the neural 
model, while the other 9 samples are used as training data. This process 
is repeated 10 times with each of the partitions used exactly once as the 
test data.   
NEURAL NETWORK CONFIGURATION 
The feed forward neural network consists of three main layers, 
which are input layer, hidden layer, and output layer. Input and output 
usually consist of 1 layer, and the hidden layer could consist of a 
minimum of 1 layer. Fig. 1 shows examples of feed forward neural 
network architecture. The number of input nodes and output nodes 
depends on the collected data, while the numbers of hidden nodes for 
ANN are based on trial and error.  
A guideline by Zhang, Patuwo and Hu (1998) recommended the 
number of hidden nodes according to “n/2”, “1n”, “2n”, and “2n+1” 
where n is the number of input nodes. Since the number of input nodes 
in this research is 61, the number of hidden nodes that will be used are 
32, 61, 122, and 123, respectively. To limit the trial and error process, 
the number of hidden layers used for this research is 1. Table 5 shows 
the structures of neural networks used in this research. 
Table 5 Proposed neural network structures. 
Input Hidden 
Layer 
Hidden 
Nodes 
Output Network 
Structures 
55 
1 
27 
4 
55-27-4 
55 55-55-4 
110 55-110-4 
111 55-111-4 
2 
27 55-27-27-4 
55 55-55-55-4 
110 55-110-110-4 
111 55-111-111-4 
Fig. 1  Feed Forward Neural Network Architecture 
Multi-layer feed forward neural networks are the most commonly 
used algorithms in medical diagnosis. The feed forward neural network 
can be described in equation (2). 
ẏ𝑙 =  𝑓 ∑ 𝑤𝑖,𝑗
𝑖
𝑥𝑖 + 𝑏𝑖
 
(2) 
Where ẏ𝑗is the output of the network, f is the transfer function, 𝑤𝑖𝑗
is the weight, 𝑥𝑖 is the input, and 𝑏𝑖 is the bias. From equation (2), the 
multi-layer feed forward neural network with 1 hidden layer can be 
further derived as: 
) are  propagated from the output 
The neural network is given input x and the error of the network 
back propagation 
Gradient descent with momentum  and adaptive  learning rate 
Gradient descent with adaptive learning rate back propagation 
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ẏ𝑙(𝑛) = 𝑓𝑘(∑ 𝑉𝑗,𝑘𝑓𝑗(
𝑁1
𝑘=1
∑ 𝑊𝑖,𝑗𝑥𝑖(𝑛) + 𝑏𝑖) + 𝑏𝑗)
𝑁0
𝑖=1
(3) 
Where, ẏ is the output of the neural network, f is the transfer 
function of the neural network, N is the number of nodes in the 
respective layer (N0 is the number of nodes in the input layer and N1 is 
the number of nodes in the 1st hidden layer), Vj,k is the weight of the 
neural network between the hidden layer and output layer, Wi,j is the 
weight from the input layer to the hidden layer, 𝑥𝑖(𝑛) is the input of the 
neural network, and 𝑏 is the bias of the neural network.  
The most commonly used transfer function in neural networks is 
the sigmoid function. For this research we used the sigmoid transfer 
function. The sigmoid transfer function (log-sigmoid) can be 
represented as equation (4): 
𝑓 =  
1
1 + 𝑒−𝑛
 
(4) 
Where n is the output of the hidden layer.  
The values of weight (Wij, Vjk, Zkl) and bias (bi, bj, bk) are 
iteratively changed by the training function in order to achieve the best 
prediction accuracy. Weight and bias are adjusted by the training 
function based on the error produced by the network. This error value 
could be obtained using the performance function. There were several 
performance functions that could be used in neural networks. We used 
MSE (Mean Squared Error) and Cross Entropy performance functions 
in this research. For multi-class classification problems, cross entropy 
is widely used as a neural network performance function. However, 
some of the training functions that use the Jacobian based matrix 
calculation (e.g. Lavenberg-Marquadt and Bayesian Regulization) used 
MSE or SSE (Sum Squared Error) for weight and bias calculations. 
Cross Entropy produces error values that heavily penalize outputs that 
are extremely inaccurate (ẏ near 1-t), with very little penalties to a fairly 
correct classification/prediction (ẏ near t). Minimizing cross entropy 
and MSE values leads to a good neural network model. Cross Entropy, 
using equation (5), produced error values and MSE using equation (6). 
𝑒𝑟𝑟𝑜𝑟 = 𝐸 = −𝑡𝑙  •  log ẏ𝑙
 
(5) 
𝑒𝑟𝑟𝑜𝑟 = 𝐸 =
1
2
(𝑡𝑙 − ẏ𝑙)
2 (6) 
Where 𝑡𝑙 is the output target and ẏ𝑙 is the neural network predicted 
output. After the error value is computed, the training algorithm will 
adjust the weight and bias of the neural network based on the error 
value. The training functions that are often used by researchers in the 
field of medical diagnosis are back propagation algorithms. Back 
propagation algorithm is a learning function and commonly used 
method for training neural networks, where it uses gradient descent 
algorithms that minimize squared error. Squared errors are minimized 
by using an iterative process of gradient descent. Gradient descent can 
be expressed in equation (7): 
𝑔𝑖  =
𝜕𝐸𝑖
𝜕𝑊𝑖
(7) 
Where 𝑔𝑖 is the gradient of the ith iteration, E is the error of the 
network for the ith iteration, and W is the weight and biases of the ith 
iteration. Weight and biases are updated in the direction of network 
error (performance function) decreases most rapidly (negative of 
gradient) using equation (8). 
𝑈𝑖+1  = 𝑈𝑖 − 𝜂𝑔𝑖 (8) 
Where 𝑈𝑖 is a vector of current weight and biases, 𝑔𝑖 is the current 
gradient, and 𝜂 is the learning rate (proportional parameter which 
defines the step length of each iteration in the negative gradient 
descent). The learning rate value is defined by the user, where the small 
value of 𝜂 could lead to a true approximation or prediction while 
slowing the learning process. However, choosing a larger value of 𝜂
could speed up the neural network convergence, which may cause 
oscillation in the weight spaces. Basically, back propagation works as 
follows:  
1.
 
network is calculated,  
2.
 
Sensitivities (𝛥 𝑊𝑖 and 𝛥 𝑏𝑖
layer to the first layer, and  
3.
 
The weight w and biases b of the neural network are updated.  
Back propagation uses the chain rule in order to compute 
derivatives of the squared error with respect to the weights and biases 
in the hidden layers.  
This algorithm is called back propagation because the derivatives 
are computed first in the last layer of the network and then propagated 
backwards through the network to compute the derivatives in the 
hidden layer. However, there are several variations of the back 
propagation algorithm. The variations of the back propagation training 
algorithm include: 
1. Lavenberg-Marquadt 
2. Bayesian Regulation back propagation. 
3. BFGS quasi-Newton backpropagation 
4. Resilient Back propagation 
5. Scaled Conjugate Gradient 
6. Conjugate Gradient with Powell/Beale Restarts 
7. Fletcher-Reeves Conjugate Gradient 
8. Polak-Ribiére Conjugate Gradient 
9. One Step Secant 
10. Gradient descent back propagation 
11.
12. Gradient descent with momentum 
13.
This research used several variations of back propagation 
algorithms, including the gradient descent method (Gradient Descent 
with Momentum, Gradient Descent with Momentum and adaptive 
learning rate), the Conjugate gradient method (Scaled Conjugate), and 
the Quasi-Newton method (Lavenberg-Marquadt). 
Gradient descent with momentum 
As mentioned previously, the low value of
 
η produces a better 
prediction/approximation but will slow the neural network 
convergences, while a larger value of η will cause the neural network to 
converge faster but will result in oscillation in the weight spaces. These 
problems can be resolved by introducing a momentum constant. The 
gradient descent with momentum constant (m) can written as: 
𝑈𝑖+1  = 𝑈𝑖 − 𝜂𝑔𝑖 +  𝑚 (9) 
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Gradient descent with momentum and adaptive learning rate 
Gradient Descent with momentum and adaptive learning rate is the 
extension of the gradient descent with momentum algorithm, where the 
learning rate is adaptively changed by the neural network instead of 
being specified by the users. The learning rates are changed according 
to these 3 rules: 
If the squared error of the training set is increased by more than the 
specified percentage ζ (which is usually between 1-5 percent) after the 
weight is updated, then the weight will be discarded. The learning rate 
then will be multiplied by some factors p (usually between the values of 
0-1) and the momentum constant will be set to zero. 
If the squared error is decreased after the weight update, then the 
weight is accepted. The learning rate then will be multiplied by some 
factors η > 1 and if the momentum constant is previously set to zero, it 
is reset to its original value. 
If the square error increases by less than ζ, then the weight update is 
accepted. The learning rate and momentum constant are unchanged. 
Levenberg-Marquadt 
The Levenberg-Marquadt was designed to minimize functions that 
are sums of squares of other nonlinear functions, and is suited for neural 
network trainings that use the mean squared error as the performance 
index. When the performance function uses the mean squared error or 
sum squared error, the Hessian matrix can be approximated as:  
𝐻 =  𝐽𝑇𝐽
 (10) 
And the gradient can be computed as: 
𝑔 =  𝐽𝑇𝐸 (11) 
Where J is the Jacobian matrix that contains the first derivatives of 
the network errors with respect to the weights and biases, and E is a 
vector of network error. The vector of current weights and biases can be 
updated using this approximation: 
𝑈𝑖+1  = 𝑈𝑖 − [𝐽
𝑇𝐽 +  µ𝐼]−1𝐽𝑇𝐸
 
(12) 
Parameter µ is adaptively changed until it reduces the network error. 
The µ value will decrease after each successful iteration that results in a 
reduction of network performance function and is only increased when 
a tentative step would increase the value of the performance function.  
The scaled conjugate gradient algorithm is based on conjugate 
directions instead of a local gradient. Conjugate gradient back 
propagation typically involves 4 steps: 
1.
 
Select the first search direction p0
 
to be the negative of the 
gradient: 
𝑝0  = −𝑔0
 
(13) 
2. The line search is then performed using equation (9) to 
determine the optimal distance to move along the current 
search direction, where 𝛼𝑘 is used as a positive scalar which 
determines the scale of the step size taken by the function 
𝐿𝑘+1  = 𝐿𝑘 + 𝛼𝑘𝑝𝑘
 
(14) 
3. Select the next search direction using:  
𝑝𝑘  = −𝑔𝑘 +  𝛽𝑘𝑝𝑘−1 (15) 
The value of β can be calculated using several functions: 
𝛽𝑘 =  
∆𝑔𝑘−1
𝑇 𝑔𝑘
∆𝑔𝑘−1
𝑇 𝑝𝑘−1
 𝑂𝑟 𝛽𝑘 =  
𝑔𝑘
𝑇𝑔𝑘
𝑔𝑘−1
𝑇 𝑔𝑘−1
  𝑂𝑟 
∆𝑔𝑘−1
𝑇 𝑔𝑘
𝑔𝑘−1
𝑇 𝑝𝑘−1
(16) 
4. If the algorithm is not converged, continue from Step 2. 
Development of neural network model 
This research proposed a method for ADHF clinical pathway 
variance prediction using an ANN model. The method used to develop 
ANN based variance prediction of ADHF clinical pathways can be 
summarized in Fig. 2. The data collection process was conducted at the 
National Heart Institute (IJN). After the data collection process, data 
analysis was conducted to identify variance and input data. Then, data 
preprocessing was conducted, along with the determination of neural 
network structures. The neural network experiment is conducted after 
the datasets and neural network structures are finalized. The experiment 
was conducted using the MATLAB R2014b on the computer with the 
following specifications: Intel Core i-7 with 2.60 GHz, RAM 12.0 GB, 
and a 64-bit processing system. The selection of the transfer function, 
training function, and performance function has been discussed in the 
Neural Network Configuration section. After the experiment has been 
conducted, the results will be compared to find the best ANN model for 
ADHF clinical pathway variance prediction. The main criteria to 
determine the best ANN model are the lowest fitness function and 
prediction accuracy. The fitness function, used for evaluation, is the 
same as the performance function used by the network to update the 
weights, which are Cross Entropy and MSE. The summary of the neural 
network configuration used in our research is shown Table 6. 
Fig. 2 ANN-based model development flowchart for ADHF clinical 
pathway variance prediction. 
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Table 6 ANN structures used for ADHF variance prediction. 
NETWORK STRUCTURES 
55-27-4 
55-55-4 
55-110-4 
55-111-4 
55-27-27-4 
55-55-27-4 
55-110-27-4 
55-111-27-4 
TRAINING FUNCTION 
Lavenber
g-
Marquadt 
Scaled 
Conjugat
e 
Gradient Descent 
with momentum 
Gradient Descent 
with momentum 
and adaptive 
learning rate 
Learnin
g Rate 
(𝜂) 
Moment
um (α) 
Initial 
Learnin
g Rate 
(𝜂) 
Moment
um (α) 
0.01 - 
0.9 
0.1 - 
0.9 
0.01 - 
0.9 
0.1 - 
0.9 
TRANSFER FUNCTION 
Sigmoid – Logsig (Hidden Layer) Softmax (Output Layer) 
PERFORMANCE FUNCTION 
Mean Squared Error (MSE) Cross Entropy 
Neural network evaluation 
The mean squared error (MSE) and prediction accuracy are used to 
evaluate the performance of the proposed neural network model. A 
good neural network model can be achieved when the MSE is low and 
the prediction accuracy is high. MSE can be calculated using equation 
(4). Prediction accuracy can be computed using equation (17). 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 = (1 − 
𝑚
𝑠
 ) 𝑥 100% (17) 
Where m s
of data samples. 
Table 7 Training function: Scaled conjugate BP (trainscg). 
Architecture 
Training 
(%) 
Test (%) 
Cross 
Entropy 
(Training) 
Cross 
Entropy 
(Test) 
55-27-4 52.38 47.24 0.831 0.865 
55-55-4 53.81 45.79 0.833 0.894 
55-110-4 52.19 44.99 0.833 0.898 
55-111-4 55.59 48.03 0.84 0.91 
55-27-27-4 55.73 50.8 0.839 0.868 
55-55-55-4 52.46 46.04 0.836 0.872 
55-110-110-4 50.52 44.35 0.836 0.889 
55-111-111-4 53.35 44.88 0.83 0.9 
Table 8 
(traingdm). 
Architecture 
Training 
(%) 
Test (%) 
Cross 
Entropy 
(Training) 
Cross 
Entropy 
(Test) 
55-27-4 54.6 47.62 0.828 0.87 
55-55-4 55.07 43.95 0.821 0.903 
55-110-4 51.7 43.03 0.834 0.912 
55-111-4 44.07 40.39 1.018 1.031 
55-27-27-4 53.78 48.42 0.84 0.868 
55-55-55-4 53.39 47.11 0.835 0.88 
55-110-110-4 41.182 45.8 0.872 0.891 
55-111-111-4 56.84 46.99 0.874 0.931 
Table 9 
adaptive learning rate BP (traingdx). 
Architecture 
Training 
(%) 
Test (%) 
Cross 
Entropy 
(Training) 
Cross 
Entropy 
(Test) 
55-27-4 54.14 47.76 0.832 0.87 
55-55-4 47.94 39.47 0.871 0.931 
55-110-4 49.02 40.65 0.863 0.922 
55-111-4 48.89 43.41 0.943 0.988 
55-27-27-4 53.64 48.94 0.841 0.867 
55-55-55-4 53.54 46.04 0.843 0.884 
55-110-110-4 43.3 40.37 0.888 0.91 
55-111-111-4 43.91 40.93 0.942 0.977 
Table 10 Training function: Levenberg-Marquardt (trainlm). 
Architecture Training 
(%) 
Test (%) 
MSE 
(Training) 
MSE 
(Test) 
55-27-4 55.02 48.94 0.303 0.319 
55-55-4 53.97 43.93 0.313 0.318 
55-110-4 58.6 44.74 0.306 0.315 
55-111-4 57.28 46.19 0.299 0.322 
55-27-27-4 57.78 50.92 0.30 0.32 
55-55-55-4 55.55 49.2 0.308 0.325 
55-110-110-4 57.74 45.93 0.302 0.322 
55-111-111-4 54.95 45.39 0.304 0.326 
The objective of this research was to find the best neural network 
model for ADHF clinical pathway variance prediction. There were 32 
different models of neural networks compared, which differ in training 
functions and network structures. Initial results show that the neural 
network with a 55-27-27-4 architecture produces the best results in the 
3 of 4 training functions used. The Levenberg-Marquadt training 
function produces the best prediction results among the other 4 training 
functions.  
However, initial results show the best overall prediction result 
(Lavenberg-Marquadt) only achieved 57.78% for the training dataset 
and 50.92% for the test dataset. The low prediction rate may be caused 
by the fact that several patients may have several variances in their 
treatment. In order to increase the neural network prediction rate, we 
changed the neural network structures in our experimental setup. We 
using the best neural network model obtained in our initial experiment 
and changed the output nodes to 1 output, where each output class is 
trained and tested separately. The network configuration used in the 
second experimental setup was: 
1. Network Structures = 55-27-27-1 
2. Training Function = Levenberg-Marquadt (trainlm) 
3. Transfer Function = Sigmoid – Logsig (Hidden Layer) and 
Satlins (Output Layer) 
4. Performance Function = MSE 
Table 11 Dialysis prediction results. 
X Fold 
Training 
(%) 
Test (%) 
MSE 
(Training) 
MSE 
(Test) 
1 93.2 86.6 0.66 0.11 
2 91.5 84.2 0.07 0.11 
3 90 76.3 0.07 0.17 
4 96.4 88.2 0.03 0.09 
5 91.9 85.5 0.07 0.12 
6 92.2 86.8 0.06 0.1 
7 93.5 94.7 0.06 0.07 
8 92.2 94.7 0.06 0.05 
9 92.2 94.7 0.06 0.05 
10 91.5 94.7 0.06 0.03 
Average 92.46 88.64 0.12 0.09 
Cardiac catheter prediction results. 
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Table 12 PCI prediction results. 
X Fold 
Training 
(%) 
Test (%) 
MSE 
(Training) 
MSE 
(Test) 
1 92.4 92.1 0.07 0.07 
2 93.2 84.2 0.07 0.15 
3 92.1 94.7 0.07 0.05 
4 91.5 97.4 0.08 0.25 
5 92.6 89.5 0.07 0.1 
6 92.2 93.4 0.06 0.06 
7 92.4 92.1 0.07 0.08 
8 92.4 92.1 0.08 0.08 
9 92.4 92.1 0.07 0.07 
10 91.9 96.1 0.08 0.03 
Average 92.31 92.37 0.072 0.094 
Table 13 Angiography prediction results. 
X Fold Training 
(%) 
Test (%) MSE 
(Training) 
MSE 
(Test) 
1 69.1 69.7 0.20 0.21 
2 70.6 72.4 0.22 0.24 
3 65.9 60.5 0.22 0.23 
4 74.6 65.8 0.16 0.23 
5 65.7 64.5 0.22 0.22 
6 70.6 65.8 0.20 0.21 
7 74.7 60.5 0.17 0.25 
8 77.3 65.8 0.16 0.20 
9 66.8 57.9 0.16 0.30 
10 64.6 73.7 0.30 0.26 
Average 69.99 65.66 0.201 0.235 
Table 14 
X Fold 
Training 
(%) 
Test (%) 
MSE 
(Training) 
MSE 
(Test) 
1 94.7 96.1 0.04 0.03 
2 96.4 98.7 0.03 0.01 
3 94.5 93.4 0.04 0.03 
4 94.5 97.4 0.04 0.02 
5 94.7 96.1 0.04 0.04 
6 94.8 94.7 0.04 0.05 
7 94.5 97.4 0.04 0.03 
8 95.4 89.5 0.03 0.09 
9 94.9 93.4 0.04 0.07 
10 95.7 86.8 0.03 0.11 
Average 95.01 94.35 0.037 0.048 
Table 15 Overall results. 
Variances Training 
(%) 
Test (%) MSE 
(Training) 
MSE 
(Test) 
Angiography 69.99 65.66 0.201 0.235 
Cardiac 
Catheter 
95.01 94.35 0.037 0.048 
Dialysis 92.46 88.64 0.12 0.09 
PCI 92.31 92.37 0.072 0.094 
Average 87.4425 85.255 0.1075 0.11675 
Discussion 
The accuracy of variance prediction improved significantly by 
changing its structure. The overall prediction rate increased to 87.445% 
from 57.78% for the training dataset, and increased from 50.92% to 
85.255% for the test dataset. It is shown that network structures play a 
significant role in improving the prediction accuracy. Generally, 
artificial neural networks performed well in predicting 3 of 4 cases of 
variance in the ADHF clinical pathway. The artificial neural network 
can predict variance cases of Cardiac Cathether, PCI, and Dialysis with 
high accuracy (around 90% accuracy). However, for the case of 
angiography, the prediction results still did not achieve the desired 
performances. 
CONCLUSION 
In this paper, the methodology of variance prediction for ADHF 
clinical pathway using an artificial neural network is presented. The 
best model of neural network has been obtained and presented. Future 
works will involve the combination of fuzzy logic with proposed neural 
network models for the improvement of classified results. Furthermore, 
the application of feature selection techniques could be used to increase 
prediction accuracy.  
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